This is especially important given that activation of cyclic nucleotide signalling in combination chemotherapy is an emerging strategy in cancer treatment.39, 40, 41 However, PKA/PKG-activation did not block caspase-3-dependent platelet apoptosis induced by the compounds (Figures 3b and c). This evidence concerns the gene CASP3 and cancer.